牛叉诊股

[{"date":"2026.04.01","stock":"3.42","trade":"4.62","ind":"1.70"},{"date":"2026.03.31","stock":"-0.73","trade":"-0.68","ind":"-1.81"},{"date":"2026.03.30","stock":"0.73","trade":"0.96","ind":"-0.25"},{"date":"2026.03.27","stock":"3.81","trade":"4.54","ind":"1.13"},{"date":"2026.03.26","stock":"-1.01","trade":"-0.58","ind":"-1.41"},{"date":"2026.03.25","stock":"0.76","trade":"1.24","ind":"1.95"},{"date":"2026.03.24","stock":"3.67","trade":"4.01","ind":"1.43"},{"date":"2026.03.23","stock":"-6.62","trade":"-5.71","ind":"-3.76"},{"date":"2026.03.20","stock":"-1.69","trade":"-2.21","ind":"-0.25"},{"date":"2026.03.19","stock":"-2.35","trade":"-2.44","ind":"-2.02"},{"date":"2026.03.18","stock":"-0.23","trade":"0.78","ind":"1.05"},{"date":"2026.03.17","stock":"-0.47","trade":"-0.82","ind":"-1.87"},{"date":"2026.03.16","stock":"0.23","trade":"0.60","ind":"0.19"},{"date":"2026.03.13","stock":"0.00","trade":"-0.10","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.47","trade":"-0.73","ind":"-0.63"},{"date":"2026.03.11","stock":"-0.69","trade":"-0.51","ind":"0.78"},{"date":"2026.03.10","stock":"0.70","trade":"2.00","ind":"2.04"},{"date":"2026.03.09","stock":"-0.46","trade":"-0.66","ind":"-0.74"},{"date":"2026.03.06","stock":"1.65","trade":"3.02","ind":"0.59"},{"date":"2026.03.05","stock":"1.44","trade":"1.11","ind":"1.23"},{"date":"2026.03.04","stock":"-1.42","trade":"-0.71","ind":"-0.75"}]

福安药业,深证成指,化学制药指数

压力支撑

该股压力位为4.15元，支撑位为4.06元。

[{"text":"\u538b\u529b\u4f4d","value":"4.15","date":1774972800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.06","date":1774972800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.5资金面打败了88%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：04月01日 20:30

机构今日流向(万元)	4315.28	机构5日流向(万元)	5867.86
机构10日流向(万元)	572.12	机构20日流向(万元)	2079.81

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2562.36万股，其中基金数没有增加，主力净减仓3家，请投资者中长期谨慎为宜。

截止2025-12-31，共20家主力机构（基金20家），持仓量总计92.29万股，占流通A股0.10%
其中，基金持仓与2025-06-30相比：
增仓：4家，增持 2.51万股
减仓：4家，减持 55.37万股
新出现在主力名单中：11家，持有26.89万股
从主力名单中消失：14家，原持有2536.39万股

消息面诊股

诊断结果：3.3消息面打败了3%的股票今日有利好新闻的公司

近期该股利空消息较多，投资时需谨慎。

消息面得分最高的股票

消息列表

重大利空	业绩预告	业绩大幅下降	2026-01-30
一般消息	股东大会	临时股东大会	2025-12-20
一般消息	高管变动	取消监事会	2025-09-15
利好	分红转增	10派0.20元(含税)	2025-08-27
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
利好	分红转增	10派0.5元(含税)	2025-04-24

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	1条	1条	0条

行业面诊股

诊断结果：7.5行业面打败了99%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.04.01","price":"1.70","value":"4.62"},{"date":"2026.03.31","price":"-1.81","value":"-0.68"},{"date":"2026.03.30","price":"-0.25","value":"0.96"},{"date":"2026.03.27","price":"1.13","value":"4.54"},{"date":"2026.03.26","price":"-1.41","value":"-0.58"},{"date":"2026.03.25","price":"1.95","value":"1.24"},{"date":"2026.03.24","price":"1.43","value":"4.01"},{"date":"2026.03.23","price":"-3.76","value":"-5.71"},{"date":"2026.03.20","price":"-0.25","value":"-2.21"},{"date":"2026.03.19","price":"-2.02","value":"-2.44"},{"date":"2026.03.18","price":"1.05","value":"0.78"},{"date":"2026.03.17","price":"-1.87","value":"-0.82"},{"date":"2026.03.16","price":"0.19","value":"0.60"},{"date":"2026.03.13","price":"-0.65","value":"-0.10"},{"date":"2026.03.12","price":"-0.63","value":"-0.73"},{"date":"2026.03.11","price":"0.78","value":"-0.51"},{"date":"2026.03.10","price":"2.04","value":"2.00"},{"date":"2026.03.09","price":"-0.74","value":"-0.66"},{"date":"2026.03.06","price":"0.59","value":"3.02"},{"date":"2026.03.05","price":"1.23","value":"1.11"},{"date":"2026.03.04","price":"-0.75","value":"-0.71"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	美诺华	95.82%	22.88%	6.2分
2	ST景峰	84.58%	12.06%	5.8分
3	华纳药厂	50.92%	32.18%	6.2分
4	联环药业	45.39%	32.89%	6.0分
5	津药药业	42.93%	45.45%	5.9分
6	信立泰	41.31%	15.78%	6.6分
7	泽璟制药	37.43%	13.65%	6.0分
8	苑东生物	35.39%	19.32%	6.6分
9	海思科	34.73%	13.90%	6.0分
10	舒泰神	33.61%	38.14%	6.4分
11	上海谊众	33.33%	17.38%	6.8分
12	百利天恒	28.71%	18.92%	5.7分
13	双鹭药业	28.01%	24.32%	5.0分
14	富祥药业	26.96%	10.52%	5.9分
15	奥锐特	26.07%	24.11%	5.5分
16	迪哲医药	24.12%	13.82%	5.8分
17	博瑞医药	23.94%	11.64%	5.2分
18	科伦药业	23.85%	9.07%	6.2分
19	翰宇药业	23.17%	13.08%	6.4分
20	一品红	22.17%	20.05%	6.0分
21	东诚药业	19.69%	14.63%	5.9分
22	亚太药业	18.64%	22.42%	5.5分
23	奥赛康	18.48%	17.89%	5.8分
24	新诺威	17.90%	16.11%	5.6分
25	宏源药业	17.90%	15.23%	6.3分
26	昂利康	17.76%	19.62%	5.8分
27	司太立	17.14%	19.02%	5.1分
28	海森药业	16.75%	18.24%	5.1分
29	盟科药业	16.34%	7.82%	5.5分
30	必贝特	15.01%	14.01%	5.9分
31	灵康药业	14.19%	10.84%	5.8分
32	前沿生物	13.57%	11.70%	5.2分
33	力生制药	12.74%	4.39%	6.1分
34	广生堂	12.61%	20.15%	5.6分
35	海辰药业	12.56%	13.85%	5.9分
36	益方生物	11.85%	22.06%	5.6分
37	北大医药	11.75%	16.31%	6.1分
38	汇宇制药	11.62%	21.77%	5.5分
39	诚意药业	11.60%	6.03%	5.9分
40	润都股份	11.59%	8.43%	5.6分
41	首药控股	11.38%	15.53%	5.3分
42	奥翔药业	11.34%	10.98%	5.3分
43	海创药业	11.28%	16.49%	5.2分
44	赛分科技	11.25%	17.53%	6.3分
45	海欣股份	11.23%	11.80%	5.8分
46	罗欣药业	10.72%	9.05%	6.0分
47	誉衡药业	10.25%	11.64%	6.8分
48	北陆药业	9.99%	10.34%	6.2分
49	京新药业	9.87%	15.10%	6.6分
50	华海药业	9.87%	9.65%	6.2分
51	共同药业	9.65%	4.45%	5.3分
52	贝达药业	9.61%	9.01%	5.8分
53	吉贝尔	9.29%	8.73%	5.1分
54	恒瑞医药	8.97%	6.71%	6.6分
55	辰欣药业	8.67%	10.30%	5.6分
56	莱美药业	8.40%	6.39%	5.7分
57	千红制药	8.34%	10.61%	6.0分
58	复星医药	8.24%	6.74%	6.3分
59	百济神州	8.06%	13.50%	6.1分
60	海正药业	8.02%	9.45%	6.3分
61	西点药业	8.00%	9.65%	5.7分
62	中关村	7.96%	7.96%	6.3分
63	普洛药业	7.85%	9.78%	5.6分
64	华东医药	7.77%	6.38%	5.9分
65	哈三联	7.75%	8.89%	4.8分
66	东北制药	7.62%	11.76%	6.2分
67	悦康药业	7.12%	11.37%	4.9分
68	健友股份	7.10%	3.32%	5.4分
69	赛托生物	6.69%	5.23%	5.4分
70	拓新药业	6.51%	4.16%	4.6分
71	立方制药	6.35%	9.51%	5.9分
72	亚虹医药	6.22%	9.75%	5.2分
73	华仁药业	5.77%	7.84%	6.7分
74	*ST三圣	5.65%	2.05%	4.9分
75	健康元	5.61%	7.58%	6.0分
76	同和药业	5.25%	9.75%	5.5分
77	微芯生物	5.19%	4.98%	5.8分
78	华润双鹤	4.85%	3.07%	6.5分
79	福元医药	4.77%	9.72%	5.9分
80	山河药辅	4.31%	6.69%	5.6分
81	复旦张江	4.29%	7.83%	5.1分
82	丰原药业	4.19%	7.70%	6.2分
83	卫信康	4.19%	6.93%	5.4分
84	莎普爱思	4.07%	6.39%	5.1分
85	哈药股份	4.06%	7.49%	5.9分
86	宣泰医药	3.90%	6.48%	4.9分
87	金石亚药	3.84%	7.54%	6.3分
88	亨迪药业	3.70%	5.20%	5.4分
89	威尔药业	3.41%	7.85%	6.0分
90	新天地	3.37%	8.00%	5.0分
91	丽珠集团	3.22%	4.55%	6.3分
92	新和成	3.12%	0.32%	5.7分
93	华北制药	3.12%	7.46%	6.0分
94	天宇股份	3.09%	10.12%	5.6分
95	海普瑞	2.94%	7.24%	5.7分
96	神奇制药	2.93%	8.97%	6.5分
97	溢多利	2.77%	2.30%	4.5分
98	金陵药业	2.66%	4.71%	5.8分
99	-	2.56%	12.95%	分
100	南新制药	2.44%	6.83%	5.1分
101	仙琚制药	2.22%	5.37%	6.5分
102	川宁生物	2.20%	0.99%	5.3分
103	纳微科技	2.18%	9.05%	5.2分
104	*ST赛隆	2.12%	-1.11%	4.5分
105	恩华药业	1.99%	6.30%	6.1分
106	国药现代	1.80%	6.44%	6.1分
107	*ST惠程	1.79%	-2.21%	4.4分
108	键凯科技	1.73%	8.62%	5.7分
109	亿帆医药	1.67%	5.60%	5.4分
110	永安药业	1.51%	5.83%	5.4分
111	福安药业	1.20%	6.28%	5.2分
112	华特达因	1.17%	0.97%	5.3分
113	德展健康	1.12%	8.43%	4.8分
114	东亚药业	0.98%	4.35%	4.8分
115	广济药业	0.95%	5.83%	5.7分
116	华邦健康	0.94%	6.75%	5.5分
117	小方制药	0.86%	5.91%	5.0分
118	圣诺生物	0.77%	10.25%	5.3分
119	尔康制药	0.76%	7.28%	5.1分
120	富士莱	0.24%	5.36%	5.2分
121	海南海药	0.18%	4.86%	5.6分
122	新华制药	-0.07%	4.70%	5.8分
123	金城医药	-0.07%	3.28%	5.9分
124	民生健康	-0.14%	3.10%	5.2分
125	九典制药	-0.34%	6.63%	5.1分
126	泰恩康	-0.45%	12.24%	4.8分
127	-	-0.56%	9.74%	分
128	能特科技	-0.89%	5.05%	5.4分
129	仟源医药	-1.00%	8.73%	6.1分
130	本立科技	-1.02%	3.68%	5.4分
131	艾力斯	-1.08%	6.75%	6.1分
132	易明医药	-1.10%	4.02%	6.1分
133	鲁抗医药	-1.28%	4.29%	5.1分
134	ST人福	-1.60%	3.42%	6.1分
135	向日葵	-1.65%	3.47%	4.9分
136	ST天圣	-1.71%	0.98%	5.2分
137	天新药业	-1.77%	2.45%	4.6分
138	河化股份	-2.34%	1.87%	5.2分
139	国邦医药	-2.45%	-2.63%	5.2分
140	-	-3.04%	3.88%	分
141	康芝药业	-3.29%	2.52%	5.1分
142	浙江医药	-4.02%	7.41%	5.9分
143	兴齐眼药	-4.05%	4.12%	6.3分
144	汉商集团	-4.60%	4.83%	5.4分
145	海翔药业	-4.72%	4.76%	6.1分
146	通化金马	-5.48%	2.53%	5.3分
147	常山药业	-5.68%	7.04%	5.2分
148	ST复华	-5.98%	1.94%	4.4分
149	-	-6.09%	5.76%	分
150	-	-6.64%	5.14%	分
151	-	-6.79%	3.31%	分
152	ST诺泰	-6.90%	4.01%	4.8分
153	-	-7.03%	4.83%	分
154	-	-7.80%	8.76%	分
155	花园生物	-8.89%	1.63%	4.4分
156	-	-9.14%	2.09%	分
157	科源制药	-12.45%	-19.82%	4.3分
158	多瑞医药	-20.34%	-21.92%	4.0分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.5基本面打败了37%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（50分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 77/219 ， 99/219。

[{"date":"2025-09-30","value":"3.76","vol":"1.50"},{"date":"2025-06-30","value":"2.56","vol":"1.22"},{"date":"2025-03-31","value":"1.56","vol":"-0.14"},{"date":"2024-12-31","value":"6.55","vol":"19.49"},{"date":"2024-09-30","value":"7.06","vol":"4.59"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	3.76	2.56	1.56	6.55	7.06
行业(%)	1.50	1.22	-0.14	19.49	4.59

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"36.68","vol":"49.37"},{"date":"2025-06-30","value":"37.14","vol":"49.34"},{"date":"2025-03-31","value":"40.74","vol":"49.16"},{"date":"2024-12-31","value":"52.96","vol":"50.51"},{"date":"2024-09-30","value":"52.96","vol":"50.38"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	36.68	37.14	40.74	52.96	52.96
行业(%)	49.37	49.34	49.16	50.51	50.38

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 142/219 ， 114/219。

[{"date":"2025-09-30","value":"-34.08","vol":"142.64"},{"date":"2025-06-30","value":"-35.76","vol":"79.13"},{"date":"2025-03-31","value":"-42.22","vol":"-0.03"},{"date":"2024-12-31","value":"-9.68","vol":"17.80"},{"date":"2024-09-30","value":"0.62","vol":"45.67"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-34.08	-35.76	-42.22	-9.68	0.62
行业(%)	142.64	79.13	-0.03	17.80	45.67

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-44.87","vol":"-2.91"},{"date":"2025-06-30","value":"-47.74","vol":"58.54"},{"date":"2025-03-31","value":"-43.63","vol":"-10.77"},{"date":"2024-12-31","value":"20.69","vol":"-75.44"},{"date":"2024-09-30","value":"19.76","vol":"-34.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-44.87	-47.74	-43.63	20.69	19.76
行业(%)	-2.91	58.54	-10.77	-75.44	-34.88

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 99/219 ， 107/219。

[{"date":"2025-09-30","value":"0.22","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.08","vol":"0.10"},{"date":"2024-12-31","value":"0.40","vol":"0.43"},{"date":"2024-09-30","value":"0.33","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.22	0.15	0.08	0.40	0.33
行业(次)	0.31	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.09","vol":"1.94"},{"date":"2025-06-30","value":"0.73","vol":"1.30"},{"date":"2025-03-31","value":"0.34","vol":"0.66"},{"date":"2024-12-31","value":"1.44","vol":"3.18"},{"date":"2024-09-30","value":"1.26","vol":"2.12"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.09	0.73	0.34	1.44	1.26
行业(次)	1.94	1.30	0.66	3.18	2.12

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"25.29","vol":"4.25"},{"date":"2025-06-30","value":"7.61","vol":"2.97"},{"date":"2025-03-31","value":"5.71","vol":"-26.71"},{"date":"2024-12-31","value":"0.69","vol":"-371.76"},{"date":"2024-09-30","value":"9.51","vol":"-10.28"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	25.29	7.61	5.71	0.69	9.51
行业	4.25	2.97	-26.71	-371.76	-10.28

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.70","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.21","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.70	-	1.21	-
行业	0.00	1.71	0.00	1.99	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 10/219 ， 46/219。

[{"date":"2025-09-30","value":"2.18","vol":"3.48"},{"date":"2025-06-30","value":"1.91","vol":"3.67"},{"date":"2025-03-31","value":"2.01","vol":"3.59"},{"date":"2024-12-31","value":"1.68","vol":"3.34"},{"date":"2024-09-30","value":"1.66","vol":"3.65"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.18	1.91	2.01	1.68	1.66
行业	3.48	3.67	3.59	3.34	3.65

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.39","vol":"2.73"},{"date":"2025-06-30","value":"1.18","vol":"2.88"},{"date":"2025-03-31","value":"1.21","vol":"2.81"},{"date":"2024-12-31","value":"0.94","vol":"2.63"},{"date":"2024-09-30","value":"1.02","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.39	1.18	1.21	0.94	1.02
行业	2.73	2.88	2.81	2.63	2.91

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 84/219 ， 89/219。

[{"date":"2025-09-30","value":"25.36","vol":"34.03"},{"date":"2025-06-30","value":"25.94","vol":"34.15"},{"date":"2025-03-31","value":"26.84","vol":"34.38"},{"date":"2024-12-31","value":"26.44","vol":"34.54"},{"date":"2024-09-30","value":"27.09","vol":"33.36"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	25.36	25.94	26.84	26.44	27.09
行业(%)	34.03	34.15	34.38	34.54	33.36

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.34","vol":"1.19"},{"date":"2025-06-30","value":"0.35","vol":"0.88"},{"date":"2025-03-31","value":"0.37","vol":"1.46"},{"date":"2024-12-31","value":"0.36","vol":"0.83"},{"date":"2024-09-30","value":"0.37","vol":"0.72"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.34	0.35	0.37	0.36	0.37
行业(%)	1.19	0.88	1.46	0.83	0.72

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"-2.97","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.05","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.32","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.80","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[福安药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]